Alex de Winter invests in life science instrumentation and clinical diagnostics startups, leading GE Ventures’ investments in Veracyte (VCYT) and RainDance Technologies. Alex joined GE Ventures from Mohr Davidow Ventures, where he served as a board director with On-Q-ity and board observer for CardioDx, Corventis, Crescendo Bioscience, DVS Sciences, and Personalis. He started his career as a research scientist with 454 Life Sciences (acquired by Roche) and Pacific Biosciences (PACB). Alex has an MBA from UC Berkeley, a Ph.D. in chemistry from Stanford, and graduated magna cum laude from Amherst College with a BA in English and Chemistry. When not working, Alex enjoys cooking and supporting/lamenting the Dallas Cowboys.
Next Team Member